Isampulu yokuKhupha iReagent
Igama lemveliso
IMakhro kunye neMicro-Test yokuKhupha iSampuli yeReagent
Isatifikethi
CE, FDA, NMPA
Amacandelo aphambili
| Igama | Amacandelo aphambili | Icandeloiinkcukacha | Ubungakanani |
| Ukukhutshwa kweSampuliireagent | I-Dithiothreitol, i-sodium dodecyli-sulfate (SDS), i-RNase inhibitor,amanzi angaphezulu, ahlambulukileyo | 0.5mL / Vial | 50 Ingqayi |
Qaphela: Amalungu kwiibhetshi ezahlukeneyo zeekiti azitshintshi.
Iimeko zokugcina kunye nobomi beshelufu
Gcina kunye nokuthutha kwiqondo lokushisa.Ubomi beshelufu ziinyanga ezingama-24.
Izixhobo ezisebenzayo
Izixhobo kunye nezixhobo ngexesha lokusetyenzwa kwesampulu, njengeepipettes, abaxube be-vortex,iibhafu zamanzi, njl.
Iimfuno zesampulu
I-swabs ye-oropharyngeal esanda kuqokelela, i-nasopharyngeal swabs.
Ukuchaneka
Xa le kiti isetyenziselwa ukutsalwa kwi-CV ye-in-house precision reference kwii-replicates ezili-10, i-coefficient of variation (CV, %) yexabiso le-Ct ayikho ngaphezu kwe-10%.
Umahluko phakathi kweebhetshi
Xa ireferensi echanekileyo yangaphakathi ivavanywa kwiibhetshi ezintathu zeekhithi phantsi kwemveliso yovavanyo xa kutsalwa ngokuphindaphindiweyo kwaye, i-coefficient of variation (CV, %) yexabiso le-Ct alikho ngaphezu kwe-10%.
Ukuthelekisa ukusebenza
● Ukuthelekisa ukusebenza kakuhle
| Ukuthelekiswa kobuchule bendlela yamaso amagnetic kunye nomkhuphi wesampulu | ||||
| ugxininiso | indlela amaso magnetic | umkhululi wesampuli | ||
| orfab | N | orfab | N | |
| 20000 | 28.01 | 28.76 | 28.6 | 29.15 |
| 2000 | 31.53 | 31.9 | 32.35 | 32.37 |
| 500 | 33.8 | 34 | 35.25 | 35.9 |
| 200 | 35.25 | 35.9 | 35.83 | 35.96 |
| 100 | 36.99 | 37.7 | 38.13 | undet |
Ukusebenza kakuhle kokutsalwa kokukhululwa kwesampulu kwakufana nendlela ye-magnetic beads, kwaye ukuxinwa kwe-pathogen ingaba yi-200Copies/mL.
● Uthelekiso lwexabiso leCV
| Ukuphindaphinda kwesicatshulwa sokukhululwa kwesampuli | ||
| ugxininiso: 5000Iikopi / ml | ORF1ab | N |
| 30.17 | 30.38 | |
| 30.09 | 30.36 | |
| 30.36 | 30.26 | |
| 30.03 | 30.48 | |
| 30.14 | 30.45 | |
| 30.31 | 30.16 | |
| 30.38 | 30.7 | |
| 30.72 | 30.79 | |
| CV | 0.73% | 0.69% |
Xa ivavanywa kwiikopi eziyi-5,000 /mL, i-CV ye-orFab ne-N yayiyi-0.73% kunye ne-0.69%, ngokulandelelanayo.
